81
Participants
Start Date
February 28, 2014
Primary Completion Date
January 27, 2017
Study Completion Date
July 28, 2021
Pomalidomide and Dexamethasone
Medizinische Universitat Wien, Vienna
Wilhelminenspital der Stadt Wien, Vienna
Krankenhaus der Elisabethinen Linz, I Interne Abteilung, Linz
Alexandra Hospital, University of Athens, Athens
Ospedale Maggiore Policlinico Mangiagalli Regina Elena, Milan
S.C. Oncologia Medica, Lecco
Hospital de La Princesa, Madrid
CEIC Hospital Universitario de Salamanca, Salamanca
Arcispedale Santa Maria Nuova, Reggio Emilia
Hospital Universitario Doctor Peset, Valencia
Azienda Ospedaliero Universitaria Ospedali, Ancona
Medizinische Klinik und Poliklinik V Hamatologie, Onkologie und Rheumatologie, Neuenheimer Feld 410
University Hospital Tubingen, Tübingen
Hopital Saint Louis, Paris
CHU de Poitiers, Poitiers
Hopital Dypuytren-CHU de Limoges, Limoges
VU University Medical Center VU Medisch Centrum, Amsterdam
Daniel den Hoed Kliniek Medical Oncology, Erasmus MC, Rotterdam
Queen Elizabeth Hospital UHB NHS Foundation Trust, Birmingham
Ninewells Hospital and Medical School, Dundee
Oxford Radcliffe Hospital ICRF Medical Oncology Unit, Headington
St Thomas' HospitalGuy's Hospital Dept. of Haematology, London
Lead Sponsor
Celgene
INDUSTRY